Inventor

OSTRAND-ROSENBERG SUZANNE

US9 patents

⚠️ This page may combine multiple inventors who share the name “OSTRAND-ROSENBERG SUZANNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV MARYLAND

3 patents

US9650429B2May 16, 2017

Soluble CD80 as a therapeutic to reverse immune suppression in cancer patients

UNIV MARYLAND21 citations92

US7807186B2Oct 5, 2010

Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines

UNIV MARYLAND5 citations65

US10377810B2Aug 13, 2019

Soluble CD80 as a therapeutic to reverse immune suppression in cancer patients

UNIV MARYLAND0 citations50

DANA FARBER CANCER INST INC

2 patents

US6149905ANov 21, 2000

Tumor cells with increased immunogenicity and uses therefor

DANA FARBER CANCER INST INC32 citations95

US8026224B2Sep 27, 2011

Tumor cells with increased immunogenicity and uses therfor

DANA FARBER CANCER INST INC1 citations59

HARVARD COLLEGE

2 patents

US5858776AJan 12, 1999

Tumor cells with increased immunogenicity and uses therefor

HARVARD COLLEGE60 citations95

US6319709B1Nov 20, 2001

Tumor cells with increased immunogenicity and uses therefor

HARVARD COLLEGE24 citations92

OSTRAND-ROSENBERG SUZANNE

2 patents

US8956619B2Feb 17, 2015

Soluble CD80 as a therapeutic to reverse immune supression in cancer patients

OSTRAND-ROSENBERG SUZANNE28 citations90

US8444965B2May 21, 2013

Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines

OSTRAND-ROSENBERG SUZANNE0 citations42